[Side effects to the clinical use of chloramphenicol, chlortetracycline and oxytetracycline; variations fecal urobilinogen, prothrombin plasma and urinary excretion of riboflavin and N-1-methyl-nicotinamide].
D002701:Chloramphenicol / Q000494:pharmacology*; D002751:Chlortetracycline / Q000494:pharmacology*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D009525:Niacin / Q000031:analogs & derivatives; D009536:Niacinamide / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D010118:Oxytetracycline / Q000494:pharmacology*; D011516:Prothrombin; D012256:Riboflavin / Q000652:urine*; D014558:Urobilinogen
D009539:Nicotinic Acids; D014558:Urobilinogen; D009536:Niacinamide; D009525:Niacin; D002701:Chloramphenicol; D011516:Prothrombin; D012256:Riboflavin; D002751:Chlortetracycline; D010118:Oxytetracycline; C008472:N-methylnicotinamide
CHLORAMPHENICOL/effects; CHLORTETRACYCLINE/effects; FECES/microbiology; NICOTINIC ACID/related compounds; OXYTETRACYCLINE/effects; UROBILINOGEN; VITAMIN B2/in urine
Efectos secundarios al uso clínico del cloramfenicol, clortetraciclina y oxitetraciclina; variaciones del urobilinógeno fecal, protrombina plasmática y excreción urinaria de riboflavina y N-1-metil-nicotinamida.